ArticleNPJ breast cancer2021
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.
Diar Aziz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it
ArticleNPJ breast cancer2021
Diar Aziz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.